Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Malignant Melanoma

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 58 articles: HTML format

Single Articles

May 2008
1. MCDERMOTT DF , Sosman JA, Gonzalez R, Hodi FS, et al
   Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group.
   J Clin Oncol. 2008;26:2178-85.
   PubMed     Related articles    Abstract available
   
   
   April 2008
2. HODI FS , Friedlander P, Corless CL, Heinrich MC, et al
   Major response to imatinib mesylate in KIT-mutated melanoma.
   J Clin Oncol. 2008;26:2046-51.
   PubMed     Related articles   
   
   
   
3. PALKA KT , Lebow RL, Weaver KD, Kressin MK, et al
   Intracranial collision metastases of small-cell lung cancer and malignant melanoma.
   J Clin Oncol. 2008;26:2042-6.
   PubMed     Related articles   
   
   
   March 2008
4. THOMPSON JA , Curti BD, Redman BG, Bhatia S, et al
   Phase I Study of Recombinant Interleukin-21 in Patients With Metastatic Melanoma and Renal Cell Carcinoma.
   J Clin Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   February 2008
5. TESTORI A , Richards J, Whitman E, Mann GB, et al
   Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.
   J Clin Oncol. 2008;26:955-62.
   PubMed     Related articles    Abstract available
   
   
   
6. LEE CC , Faries MB, Wanek LA, Morton DL, et al
   Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma.
   J Clin Oncol. 2008;26:535-41.
   PubMed     Related articles    Abstract available
   
   
   
7. KORN EL , Liu PY, Lee SJ, Chapman JA, et al
   Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials.
   J Clin Oncol. 2008;26:527-34.
   PubMed     Related articles    Abstract available
   
   
   
8. GIMOTTY PA , Guerry D, Flaherty K
   Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients.
   J Clin Oncol. 2008;26:517-8.
   PubMed     Related articles   
   
   
   January 2008
9. BALCH CM , Soong SJ
   Predicting outcomes in metastatic melanoma.
   J Clin Oncol. 2008;26:168-9.
   PubMed     Related articles   
   
   
   
10. ZELL JA , Cinar P, Mobasher M, Ziogas A, et al
    Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment.
    J Clin Oncol. 2008;26:66-75.
    PubMed     Related articles    Abstract available
    
    
    December 2007
11. BOESEN EH , Boesen SH, Frederiksen K, Ross L, et al
    Survival after a psychoeducational intervention for patients with cutaneous malignant melanoma: a replication study.
    J Clin Oncol. 2007;25:5698-703.
    PubMed     Related articles    Abstract available
    
    
    
12. IVES NJ , Stowe RL, Lorigan P, Wheatley K, et al
    Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients.
    J Clin Oncol. 2007;25:5426-34.
    PubMed     Related articles    Abstract available
    
    
    November 2007
13. GHIORZO P , Gargiulo S, Nasti S, Pastorino L, et al
    Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy.
    J Clin Oncol. 2007;25:5336-7.
    PubMed     Related articles   
    
    
    October 2007
14. WHEATLEY K , Ives NJ, Lorigan P
    Does adjuvant vaccine therapy really have activity in malignant melanoma?
    J Clin Oncol. 2007;25:4693.
    PubMed     Related articles   
    
    
    
15. FERRETTI G , Felici A, Cognetti F, Mandala M, et al
    Transforming growth factor-beta signaling and regulatory T cells.
    J Clin Oncol. 2007;25:4695-6.
    PubMed     Related articles   
    
    
    
16. GILL S , Shapiro J, Westerman D, Prince HM, et al
    Long-term survival and secondary acute leukemia after fotemustine therapy for metastatic melanoma.
    J Clin Oncol. 2007;25:4493-4.
    PubMed     Related articles   
    
    
    September 2007
17. TARHINI AA , Kirkwood JM, Gooding WE, Cai C, et al
    Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapy.
    J Clin Oncol. 2007;25:3802-7.
    PubMed     Related articles    Abstract available
    
    
    
18. MCDERMOTT DF , Atkins MB
    More support for the judicious use of high-dose interleukin-2 in patients with advanced melanoma.
    J Clin Oncol. 2007;25:3791-3.
    PubMed     Related articles   
    
    
    July 2007
19. HANSSON J , Bergenmar M, Hofer PA, Lundell G, et al
    Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.
    J Clin Oncol. 2007;25:2819-24.
    PubMed     Related articles    Abstract available
    
    
    June 2007
20. FILIPAZZI P , Valenti R, Huber V, Pilla L, et al
    Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.
    J Clin Oncol. 2007;25:2546-53.
    PubMed     Related articles    Abstract available
    
    
    
21. RANSON M , Hersey P, Thompson D, Beith J, et al
    Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma.
    J Clin Oncol. 2007;25:2540-5.
    PubMed     Related articles    Abstract available
    
    
    
22. BEYER M , Schultze JL
    CD4+CD25highFOXP3+ regulatory T cells in peripheral blood are primarily of effector memory phenotype.
    J Clin Oncol. 2007;25:2628-30.
    PubMed     Related articles   
    
    
    
23. CORMIER JN , Xing Y, Ding M, Cantor SB, et al
    Cost effectiveness of adjuvant interferon in node-positive melanoma.
    J Clin Oncol. 2007;25:2442-8.
    PubMed     Related articles    Abstract available
    
    
    
24. PALMIERI G , Casula M, Ascierto PA, Tanda F, et al
    Molecular classification of patients with malignant melanoma for new therapeutic strategies.
    J Clin Oncol. 2007;25:e20-1.
    PubMed     Related articles   
    
    
    May 2007
25. MITCHELL MS , Abrams J, Thompson JA, Kashani-Sabet M, et al
    Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.
    J Clin Oncol. 2007;25:2078-85.
    PubMed     Related articles    Abstract available
    
    
    April 2007
26. FECHER LA , Cummings SD, Keefe MJ, Alani RM, et al
    Toward a molecular classification of melanoma.
    J Clin Oncol. 2007;25:1606-20.
    PubMed     Related articles    Abstract available
    
    
    
27. MOCELLIN S , Hoon DS, Pilati P, Rossi CR, et al
    Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis.
    J Clin Oncol. 2007;25:1588-95.
    PubMed     Related articles    Abstract available
    
    
    
28. SCHMIDT H , Suciu S, Punt CJ, Gore M, et al
    Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
    J Clin Oncol. 2007;25:1562-9.
    PubMed     Related articles    Abstract available
    
    
    
29. LEJEUNE FJ , Eggermont AM
    Hyperthermic isolated limb perfusion with tumor necrosis factor is a useful therapy for advanced melanoma of the limbs.
    J Clin Oncol. 2007;25:1449-50.
    PubMed     Related articles   
    
    
    
30. LANGE JR , Palis BE, Chang DC, Soong SJ, et al
    Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base.
    J Clin Oncol. 2007;25:1363-8.
    PubMed     Related articles    Abstract available
    
    
    March 2007
31. GARRIDO-LAGUNA I , Ponz M, Espinos J
    Is there any reason to delay introduction of tumor necrosis factor in the management of in-transit metastasis of unresectable melanoma?
    J Clin Oncol. 2007;25:1149.
    PubMed     Related articles   
    
    
    
32. QUAGLINO P , Osella-Abate S, Savoia P, Bernengo MG, et al
    What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients?
    J Clin Oncol. 2007;25:1140-1.
    PubMed     Related articles   
    
    
    
33. GIMOTTY PA , Elder DE, Fraker DL, Botbyl J, et al
    Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
    J Clin Oncol. 2007;25:1129-34.
    PubMed     Related articles    Abstract available
    
    
    
34. SCHULZ-ERTNER D , Tsujii H
    Particle radiation therapy using proton and heavier ion beams.
    J Clin Oncol. 2007;25:953-64.
    PubMed     Related articles    Abstract available
    
    
    
35. TAYLOR RC , Patel A, Panageas KS, Busam KJ, et al
    Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    J Clin Oncol. 2007;25:869-75.
    PubMed     Related articles    Abstract available
    
    
    
36. BECKER JC , Brocker EB, Schadendorf D, Ugurel S, et al
    Imatinib in Melanoma: A Selective Treatment Option Based on KIT Mutation Status?
    J Clin Oncol. 2007;25:e9.
    PubMed     Related articles   
    
    
    February 2007
37. BRAMKAMP M , Dedes KJ, Strobel K, Pahnke J, et al
    Cholestasis from malignant melanoma.
    J Clin Oncol. 2007;25:725-6.
    PubMed     Related articles   
    
    
    December 2006
38. PASHENKOV M , Goess G, Wagner C, Hormann M, et al
    Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma.
    J Clin Oncol. 2006;24:5716-24.
    PubMed     Related articles    Abstract available
    
    
    
39. FERRETTI G , Felici A, Pino MS, Cognetti F, et al
    Does CTLA4 influence the suppressive effect of CD25+CD4+ regulatory T cells?
    J Clin Oncol. 2006;24:5469-70.
    PubMed     Related articles   
    
    
    November 2006
40. MIRANDA EP
    Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in sentinel lymph node-positive melanoma.
    J Clin Oncol. 2006;24:5178.
    PubMed     Related articles   
    
    
    
41. MACKENSEN A , Meidenbauer N, Vogl S, Laumer M, et al
    Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.
    J Clin Oncol. 2006;24:5060-9.
    PubMed     Related articles    Abstract available
    
    
    October 2006
42. RANGEL J , Torabian S, Shaikh L, Nosrati M, et al
    Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.
    J Clin Oncol. 2006;24:4565-9.
    PubMed     Related articles    Abstract available
    
    
    September 2006
43. CASCINELLI N , Bombardieri E, Bufalino R, Camerini T, et al
    Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival.
    J Clin Oncol. 2006;24:4464-71.
    PubMed     Related articles    Abstract available
    
    
    
44. BEDIKIAN AY , Millward M, Pehamberger H, Conry R, et al
    Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group.
    J Clin Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
45. EGGERMONT AM
    Reaching First Base in the Treatment of Metastatic Melanoma.
    J Clin Oncol. 2006;.
    PubMed     Related articles   
    
    
    
46. CORNETT WR , McCall LM, Petersen RP, Ross MI, et al
    Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
    J Clin Oncol. 2006;24:4196-201.
    PubMed     Related articles    Abstract available
    
    
    August 2006
47. CURTIN JA , Busam K, Pinkel D, Bastian BC, et al
    Somatic Activation of KIT in Distinct Subtypes of Melanoma.
    J Clin Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    July 2006
48. DEJACO C , Duftner C, Schirmer M
    Induction of tolerance in autoimmune diseases rather than cure of cancer by interleukin-2 therapy.
    J Clin Oncol. 2006;24:e34.
    PubMed     Related articles   
    
    
    
49. WHITEMAN DC , Stickley M, Watt P, Hughes MC, et al
    Anatomic site, sun exposure, and risk of cutaneous melanoma.
    J Clin Oncol. 2006;24:3172-7.
    PubMed     Related articles    Abstract available
    
    
    
50. MOSCHOS SJ , Edington HD, Land SR, Rao UN, et al
    Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses.
    J Clin Oncol. 2006;24:3164-71.
    PubMed     Related articles    Abstract available
    
    
    
51. LEWIS KD , Robinson WA, McCarter M, Pearlman N, et al
    Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.
    J Clin Oncol. 2006;24:3157-63.
    PubMed     Related articles    Abstract available
    
    
    June 2006
52. REU FJ , Bae SI, Cherkassky L, Leaman DW, et al
    Overcoming Resistance to Interferon-Induced Apoptosis of Renal Carcinoma and Melanoma Cells by DNA Demethylation.
    J Clin Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
53. KRETSCHMER L , Hilgers R
    Research Supports the View that Sentinel Node Biopsy Is the Standard of Care in High-Risk Primary Melanoma.
    J Clin Oncol. 2006;24:2965-6.
    PubMed     Related articles   
    
    
    
54. ALOIA TA , Gershenwald JE, Andtbacka RH, Johnson MM, et al
    Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
    J Clin Oncol. 2006;24:2858-65.
    PubMed     Related articles    Abstract available
    
    
    
55. SCOGGINS CR , Ross MI, Reintgen DS, Noyes RD, et al
    Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
    J Clin Oncol. 2006;24:2849-57.
    PubMed     Related articles    Abstract available
    
    
    May 2006
56. FEARS TR , Guerry D 4th, Pfeiffer RM, Sagebiel RW, et al
    Identifying Individuals at High Risk of Melanoma: A Practical Predictor of Absolute Risk.
    J Clin Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
57. MEYSKENS FL JR , Ransohoff DF
    Predicting Risk for the Appearance of Melanoma.
    J Clin Oncol. 2006;.
    PubMed     Related articles   
    
    
    
58. BECK KE , Blansfield JA, Tran KQ, Feldman AL, et al
    Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.
    J Clin Oncol. 2006;24:2283-9.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: